Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B
Xie-Er Liang, Yong-Peng Chen
[ Html ]
[ PDF ] 368-375
doi:10.14218/JCTH.2017.00006
Non-alcoholic Fatty Liver Disease: A Clinical Update
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran
[ Html ]
[ PDF ] 384-393
doi:10.14218/JCTH.2017.00013
18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma
Arno Kornberg, Martina Schernhammer, Helmut Friess
[ Html ]
[ PDF ] 224-234
doi:10.14218/JCTH.2017.00014
Assessment of the Visual Analogue Score in the Evaluation of the Pruritus of Cholestasis
Nora V. Bergasa, E. Anthony Jones
[ Html ]
[ PDF ] 203-207
doi:10.14218/JCTH.2017.00001
Vitamin D Is Associated with Severity and Mortality of Non-alcoholic Fatty Liver Disease: A US Population-based Study
Hyun-Seok Kim, Laura Rotundo, Neil Kothari, Sung-Hoon Kim, Nikolaos Pyrsopoulos
[ Html ]
[ PDF ] 185-192
doi:10.14218/JCTH.2017.00025
Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
Ramesh Kumar, Shantam Mohan
[ Html ]
[ PDF ] 216-223
doi:10.14218/JCTH.2016.00068
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
Hiroshi Fukui
[ Html ]
[ PDF ] 249-260
doi:10.14218/JCTH.2017.00008
Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
Mark CC Cheah, Arthur J McCullough, George Boon-Bee Goh
[ Html ]
[ PDF ] 261-271
doi:10.14218/JCTH.2017.00009
Comment on ‘Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites’
Furqan Ahmed
[ Html ]
[ PDF ] 184-184
doi:10.14218/JCTH.2017.00026
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives
Emanuele Rinninella, Lucia Cerrito, Irene Spinelli, Marco Cintoni, Maria Cristina Mele, Maurizio Pompili, Antonio Gasbarrini
[ Html ]
[ PDF ] 235-248
doi:10.14218/JCTH.2017.00002
Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease
Ibrahim H. Borai, Yehia Shaker, Maha Moustafa Kamal, Wafaa M. Ezzat, Esmat Ashour, Mie Afify, Weaam Gouda, Maha M. Elbrashy
[ Html ]
[ PDF ] 109-118
doi:10.14218/JCTH.2017.00004